HBV - Hot Topics 2019
HBV - Hot Topics 2019
- Current standard of care to treat HBV
- qHBsAg utilization in practice today
- Biomarkers for HBV drug development
- New drugs for HBV cure
- HDV
- TDF, ETV difference in risk for HCC
Dr. Gish is a Hepatologist specializing in all forms of liver disease, liver cancer and liver transplant. Dr. Gish has partnered with TeleMed2U to provide telemedicine consultative services for patients with liver disease.
WHAT:TeleMed2U is a telemedicine-based multi-specialty clinical practice increasing access to specialist providers providing, “healthcare anywhere and everywhere.” The telemedicine consultation will be conducted through our HIPAA and HITECH compliant platform. Connectivity testing will be done in advance to ensure you can connect via our telemedicine platform. Following the consultation, a clinical note will be provided including a summary of your liver consultation with Dr. Gish and his consultative recommendations.
COST:Payment will be processed through an online secure transaction portal. The fees for consultative services are:
If you’d like to continue, please click Next to complete the form and we will contact you to schedule connectivity testing. During the test you will have the opportunity to determine the method of providing medical records, discuss appointment availability as well as discuss any additional questions that you have. If you are a healthcare facility interested in services, please complete the form and we can discuss the options that are right for you and your patients.
HBV - Hot Topics 2019
- Current standard of care to treat HBV
- qHBsAg utilization in practice today
- Biomarkers for HBV drug development
- New drugs for HBV cure
- HDV
- TDF, ETV difference in risk for HCC